Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00178-20.
Coronaviruses (CoVs) encode multiple interferon (IFN) antagonists that modulate the host response to virus replication. Here, we evaluated the host transcriptional response to infection with murine coronaviruses encoding independent mutations in one of two different viral antagonists, the deubiquitinase (DUB) within nonstructural protein 3 or the endoribonuclease (EndoU) within nonstructural protein 15. We used transcriptomics approaches to compare the scope and kinetics of the host response to the wild-type (WT), DUBmut, and EndoUmut viruses in infected macrophages. We found that the EndoUmut virus activates a focused response that predominantly involves type I interferons and interferon-related genes, whereas the WT and DUBmut viruses more broadly stimulate upregulation of over 2,800 genes, including networks associated with activating the unfolded protein response (UPR) and the proinflammatory response associated with viral pathogenesis. This study highlights the role of viral interferon antagonists in shaping the kinetics and magnitude of the host response during virus infection and demonstrates that inactivating a dominant viral antagonist, the coronavirus endoribonuclease, dramatically alters the host response in macrophages. Macrophages are an important cell type during coronavirus infections because they "notice" the infection and respond by inducing type I interferons, which limits virus replication. In turn, coronaviruses encode proteins that mitigate the cell's ability to signal an interferon response. Here, we evaluated the host macrophage response to two independent mutant coronaviruses, one with reduced deubiquitinating activity (DUBmut) and the other containing an inactivated endoribonuclease (EndoUmut). We observed a rapid, robust, and focused response to the EndoUmut virus, which was characterized by enhanced expression of interferon and interferon-related genes. In contrast, wild-type virus and the DUBmut virus elicited a more limited interferon response and ultimately activated over 2,800 genes, including players in the unfolded protein response and proinflammatory pathways associated with progression of significant disease. This study reveals that EndoU activity substantially contributes to the ability of coronaviruses to evade the host innate response and to replicate in macrophages.
冠状病毒(CoV)编码多种干扰素(IFN)拮抗剂,这些拮抗剂调节宿主对病毒复制的反应。在这里,我们评估了感染编码两种不同病毒拮抗剂之一(非结构蛋白 3 中的去泛素化酶(DUB)或非结构蛋白 15 中的内切核酸酶(EndoU)中的独立突变的鼠冠状病毒时,宿主的转录反应。我们使用转录组学方法比较了感染巨噬细胞中野生型(WT)、DUBmut 和 EndoUmut 病毒的宿主反应的范围和动力学。我们发现,EndoUmut 病毒激活了一个专注的反应,主要涉及 I 型干扰素和干扰素相关基因,而 WT 和 DUBmut 病毒更广泛地刺激了超过 2800 个基因的上调,包括与激活未折叠蛋白反应(UPR)和与病毒发病机制相关的促炎反应相关的网络。这项研究强调了病毒干扰素拮抗剂在塑造病毒感染过程中宿主反应的范围和幅度方面的作用,并表明失活一种主要的病毒拮抗剂,冠状病毒内切核酸酶,会极大地改变巨噬细胞中的宿主反应。巨噬细胞是冠状病毒感染期间的重要细胞类型,因为它们“注意”到感染并通过诱导 I 型干扰素来响应,这限制了病毒复制。反过来,冠状病毒编码的蛋白质减轻了细胞发出干扰素反应的能力。在这里,我们评估了两种独立的突变冠状病毒对宿主巨噬细胞的反应,一种具有降低的去泛素化活性(DUBmut),另一种含有失活的内切核酸酶(EndoUmut)。我们观察到对 EndoUmut 病毒的快速、强大和专注的反应,其特征是干扰素和干扰素相关基因的表达增强。相比之下,野生型病毒和 DUBmut 病毒引发了更有限的干扰素反应,最终激活了超过 2800 个基因,包括未折叠蛋白反应和与疾病进展相关的促炎途径中的参与者。这项研究表明,EndoU 活性极大地促进了冠状病毒逃避宿主先天反应并在巨噬细胞中复制的能力。